MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Mitochondrial DNA variants function as potential genetic risk factors for Parkinson disease

X. Zhang, T. Li, Z.-F. Fan, B.-L. Hu, J.-H. Zhu (Wenzhou, China)

Meeting: 2017 International Congress

Abstract Number: 1030

Keywords: Mitochondrial DNA(mtDNA), Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To understand whether mtDNA variants contribute to the susceptibility to sporadic PD.

Background: It is well-recognized that mitochondrial (mt) dysfunction is involved in the pathogenesis of Parkinson disease (PD). The mtDNA displacement loop (D-loop) is known to accumulate structural alterations and mutations.

Methods: A total of 500 PD patients and 505 controls recruited from East China were analyzed for variations in the D-loop region.

Results: A total of 88 single nucleotide polymorphisms (SNPs), 2 deletions and 1 insertion were detected in the D-loop region with frequencies greater than 1%. Among them, 7 SNPs had significantly different incidences between PD patients and controls (P < 0.05). Following adjustment using the covariates of age and sex, 5 SNPs remained with statistical significance (P < 0.05). In detail, the frequencies of SNPs 151-T, 318-T, 16086-C, 16134-C and 16271-C in PD patients were 3.02, 8.53, 3.31, 6.05, and 6.53 time, respectively, higher than in the controls. Further analysis in haplogroups showed that the A5 haplogroup in PD patients had a significantly higher frequency (OR 3.93, 95% CI 1.072-14.408; P < 0.05). Meanwhile, the B5 exhibited a trend of protection against risk towards PD, which appeared statistically significant in a meta-analysis combining another Asian population (OR 0.53, 95% CI 0.38-0.75; P < 0.001).

Conclusions: Our study suggests that mtDNA variants modulate risk for Parkinson disease.

To cite this abstract in AMA style:

X. Zhang, T. Li, Z.-F. Fan, B.-L. Hu, J.-H. Zhu. Mitochondrial DNA variants function as potential genetic risk factors for Parkinson disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/mitochondrial-dna-variants-function-as-potential-genetic-risk-factors-for-parkinson-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/mitochondrial-dna-variants-function-as-potential-genetic-risk-factors-for-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley